全球药用赋形剂市场规模、成长率和趋势分析：依功能、应用和产品的预测（至2032年）

药用赋形剂市场规模2023年为92.7亿美元，预计将从2024年的100.2亿美元，在预测期内年复合成长率为7.03%，到2032年将成长到184.8亿美元规模。

对多功能赋形剂的需求不断成长以及仿製药使用的增加是推动市场扩张的主要因素。

药用赋形剂也用于增强药物的风味，提高依从性，尤其是年轻患者的依从性。药物赋形剂可以来自有机和无机来源，这取决于它们的化学成分。对功能性赋形剂的需求不断成长、最近的专利到期以及奈米技术的快速进步是推动药用赋形剂市场的主要因素。将赋形剂添加到含有少量药物的固体剂型中，以实现长期稳定、增强最终剂型中活性成分的效力以及其他目的。此外，赋形剂也用于改善药物製剂的性质，例如增加药物溶解度、降低黏度和改善药物吸收。

依地域的展望

预计2022年欧洲药用赋形剂市场规模将达到 25.1亿美元，并以显着的年复合成长率成长。随着药品专利到期日的临近，许多欧洲国家都开始关注仿製药产业。德国、英国和法国等欧洲国家预计在预测期内将呈现显着的成长率。预计该地区对药用赋形剂的需求将越来越大。

北美在药用赋形剂市场占有第二大占有率。在预测期内，由于製药业的快速发展、对功能性添加剂的需求不断成长、行业领先企业的存在、技术进步等，预计市场将大幅成长。

估计2024年至2032年，亚太地区药用赋形剂市场将以最快的年复合成长率成长。

本报告调查了全球药用赋形剂市场，提供市场的定义和概述，市场成长的各种影响因素分析，市场规模推移和预测，各种区分、地区/主要国家的细分，竞争环境，主要企业概况等彙整资料。

目次

第1章 执行摘要

第2章 市场概要

第3章 研究方法

第4章 市场力学

• 概要
• 促进要因
• 抑制要因
• 机会

第5章 市场要因分析

• 价值链分析
• 波特五力分析
• 新冠肺炎（COVID-19）影响分析

第6章 全球药用赋形剂市场：依类型

• 概要
• 医药填充剂
• 黏合剂
• 涂层
• 崩解剂
• 防腐剂
• 其他

第7章 全球药用赋形剂市场：依产品

• 概要
• 有机化学品
• 无机化学品

第8章 全球药用赋形剂市场：依应用分类

• 概要
• 经口
• 局部
• 非经口
• 其他

第9章 全球药用赋形剂市场：依地区

• 概要
• 北美
• 欧洲
• 亚太地区
• 其他领域

第10章 企业情势

• 概要
• 竞争分析
• 市场占有率分析
• 主要成长策略
• 竞争基准测试
• 在多项开发方面处于领先地位的公司
• 主要发展/成长策略
• 主要公司的财务矩阵

第11章 公司简介

• EVONIK INDUSTRIES AG
• BASF SE
• FERRO CORPORATION
• P&G CHEMICALS
• FMC CORPORATION
• THE DOW CHEMICAL COMPANY
• ASHLAND, INC.
• CRODA INTERNATIONAL PLC
• AKZO NOBEL NV
• INNOPHOS

第12章 附录

Global Pharmaceutical Excipients Market Size, Growth and Trends Analysis by Function (Pharmaceutical Fillers, Binders, Coatings, Disintegrants, Preservatives, Others), Application (Oral, Parenteral, Topical, Others), Product (Organic Chemicals, Inorganic Chemicals) - Industry Forecast 2032

Market Snapshot

The size of the pharmaceutical excipients market was estimated at USD 9.27 billion in 2023 and is expected to increase at a compound annual growth rate (CAGR) of 7.03% from 2024 to 2032, from USD 10.02 billion in 2024 to USD 18.48 billion by 2032. The growing need for multifunctional excipients and the growing use of generic drugs are the primary factors propelling market expansion.

Furthermore, the market for pharmaceutical excipients is used to enhance the medication's flavor, which increases patient compliance, especially in young patients. Pharmaceutical excipients can come from both organic and inorganic sources, depending on their chemical composition. The growing need for functional excipients, recent patent expirations that increase consumer demand for pharmaceutical excipients, and the rapid advancement of nanotechnology are the primary factors propelling the pharmaceutical excipients market. For long-term stabilization, to increase the potency of the active ingredient in the final dosage form, or for any other purpose, excipients can be added to solid formulations that contain small APIs. Additionally, excipients are used to improve the properties of medicinal formulations, including increasing API solubility, decreasing viscosity, and improving drug absorption.

Market Segments Insights

Pharmaceutical fillers, binders, coatings, disintegrants, preservatives, and others are among the market sectors for pharmaceutical excipients based on their operational roles.

By-products have been separated into organic and inorganic compounds according to market data for pharmaceutical excipients.

The pharmaceutical excipients market has been divided into several segments based on applications, including parenteral, topical, and oral.

Regional Perspectives

The market insights by region in the survey encompass Asia-Pacific, Europe, North America, and the rest of the globe. The pharmaceutical excipients market in Europe was estimated to be worth USD 2.51 billion in 2022 and was projected to grow at a significant compound annual growth rate. Many European nations concentrate on the generics industry because of the approaching expiration dates of pharmaceutical patents. Therefore, it is expected that European nations such as Germany, the United Kingdom, France, and others will have notable growth rates over the forecast period. Pharmaceutical excipients are expected to become more and more necessary in the region.

North America has the second-largest proportion of the pharmaceutical excipients market. Over the course of the projection period, the market is expected to increase significantly due to the quickly increasing pharmaceutical sector, rising demand for functional excipients, strong competitors in the industry, and technological advancements.

The Asia-Pacific pharmaceutical excipients market is projected to grow at the fastest compound annual growth rate (CAGR) from 2024 to 2032. According to a recent study, China's overall revenue from traditional pharmaceutical sales is expected to increase over the coming years.

Key Players

Evonik Industries Ag, Basf Se, Ferro Corporation, P&G Chemicals, Akzo Nobel NV, FMC Corporation, The Dow Chemical Company, Ashland, Inc., and Croda International PLC are a few of the major players in the pharmaceutical excipients industry.

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

• 2.1. DEFINITION
• 2.2. SCOPE OF THE STUDY
  • 2.2.1. RESEARCH OBJECTIVE
  • 2.2.2. ASSUMPTIONS
  • 2.2.3. LIMITATIONS

3. RESEARCH METHODOLOGY

• 3.1. OVERVIEW
• 3.2. DATA MINING
• 3.3. SECONDARY RESEARCH
• 3.4. PRIMARY RESEARCH
  • 3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • 3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5. FORECASTING TECHNIQUE
• 3.6. MARKET SIZE ESTIMATION
  • 3.6.1. BOTTOM-UP APPROACH
  • 3.6.2. TOP-DOWN APPROACH
• 3.7. DATA TRIANGULATION
• 3.8. VALIDATION

4. MARKET DYNAMICS

• 4.1. OVERVIEW
• 4.2. DRIVERS
• 4.3. RESTRAINTS
• 4.4. OPPORTUNITIES

5. MARKET FACTOR ANALYSIS

• 5.1. VALUE CHAIN ANALYSIS
• 5.2. PORTER'S FIVE FORCES ANALYSIS
  • 5.2.1. BARGAINING POWER OF SUPPLIERS
  • 5.2.2. BARGAINING POWER OF BUYERS
  • 5.2.3. THREAT OF NEW ENTRANTS
  • 5.2.4. THREAT OF SUBSTITUTES
  • 5.2.5. INTENSITY OF RIVALRY
• 5.3. COVID-19 IMPACT ANALYSIS
  • 5.3.1. MARKET IMPACT ANALYSIS
  • 5.3.2. REGIONAL IMPACT
  • 5.3.3. OPPORTUNITY AND THREAT ANALYSIS

6. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE

• 6.1. OVERVIEW
• 6.2. PHARMACEUTICAL FILLERS
• 6.3. BINDERS
• 6.4. COATINGS
• 6.5. DISINTEGRANTS
• 6.6. PRESERVATIVES
• 6.7. OTHERS

7. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT

• 7.1. OVERVIEW
• 7.2. ORGANIC CHEMICALS
• 7.3. INORGANIC CHEMICALS

8. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION

• 8.1. OVERVIEW
• 8.2. ORAL
• 8.3. TOPICAL
• 8.4. PARENTERAL
• 8.5. OTHERS

9. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION

• 9.1. OVERVIEW
• 9.1. NORTH AMERICA
  • 9.1.1. US
  • 9.1.2. CANADA
• 9.2. EUROPE
  • 9.2.1. GERMANY
  • 9.2.2. FRANCE
  • 9.2.3. UK
  • 9.2.4. ITALY
  • 9.2.5. SPAIN
  • 9.2.6. REST OF EUROPE
• 9.3. ASIA-PACIFIC
  • 9.3.1. CHINA
  • 9.3.2. INDIA
  • 9.3.3. JAPAN
  • 9.3.4. SOUTH KOREA
  • 9.3.5. AUSTRALIA
  • 9.3.6. REST OF ASIA-PACIFIC
• 9.4. REST OF THE WORLD
  • 9.4.1. MIDDLE EAST
  • 9.4.2. AFRICA
  • 9.4.3. LATIN AMERICA

10. COMPANY LANDSCAPE

• 10.1. OVERVIEW
• 10.2. COMPETITIVE ANALYSIS
• 10.3. MARKET SHARE ANALYSIS
• 10.4. MAJOR GROWTH STRATEGY IN THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
• 10.5. COMPETITIVE BENCHMARKING
• 10.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
• 10.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
  • 10.7.1. NEW PRODUCT LAUNCH
  • 10.7.2. MERGER & ACQUISITIONS
  • 10.7.3. JOINT VENTURES
• 10.8. MAJOR PLAYERS FINANCIAL MATRIX
  • 10.8.1. SALES & OPERATING INCOME,
  • 10.8.2. MAJOR PLAYERS R&D EXPENDITURE.

11. COMPANY PROFILES

• 11.1. EVONIK INDUSTRIES AG
  • 11.1.1. COMPANY OVERVIEW
  • 11.1.2. FINANCIAL OVERVIEW
  • 11.1.3. PRODUCT OFFERED
  • 11.1.4. KEY DEVELOPMENTS
  • 11.1.5. SWOT ANALYSIS
  • 11.1.6. KEY STRATEGIES
• 11.2. BASF SE
  • 11.2.1. COMPANY OVERVIEW
  • 11.2.2. FINANCIAL OVERVIEW
  • 11.2.3. PRODUCT OFFERED
  • 11.2.4. KEY DEVELOPMENTS
  • 11.2.5. SWOT ANALYSIS
  • 11.2.6. KEY STRATEGIES
• 11.3. FERRO CORPORATION
  • 11.3.1. COMPANY OVERVIEW
  • 11.3.2. FINANCIAL OVERVIEW
  • 11.3.3. PRODUCT OFFERED
  • 11.3.4. KEY DEVELOPMENTS
  • 11.3.5. SWOT ANALYSIS
  • 11.3.6. KEY STRATEGIES
• 11.4. P&G CHEMICALS
  • 11.4.1. COMPANY OVERVIEW
  • 11.4.2. FINANCIAL OVERVIEW
  • 11.4.3. PRODUCT OFFERED
  • 11.4.4. KEY DEVELOPMENTS
  • 11.4.5. SWOT ANALYSIS
  • 11.4.6. KEY STRATEGIES
• 11.5. FMC CORPORATION
  • 11.5.1. COMPANY OVERVIEW
  • 11.5.2. FINANCIAL OVERVIEW
  • 11.5.3. PRODUCT OFFERED
  • 11.5.4. KEY DEVELOPMENTS
  • 11.5.5. SWOT ANALYSIS
  • 11.5.6. KEY STRATEGIES
• 11.6. THE DOW CHEMICAL COMPANY
  • 11.6.1. COMPANY OVERVIEW
  • 11.6.2. FINANCIAL OVERVIEW
  • 11.6.3. PRODUCT OFFERED
  • 11.6.4. KEY DEVELOPMENTS
  • 11.6.5. SWOT ANALYSIS
  • 11.6.6. KEY STRATEGIES
• 11.7. ASHLAND, INC.
  • 11.7.1. COMPANY OVERVIEW
  • 11.7.2. FINANCIAL OVERVIEW
  • 11.7.3. PRODUCT OFFERED
  • 11.7.4. KEY DEVELOPMENTS
  • 11.7.5. SWOT ANALYSIS
  • 11.7.6. KEY STRATEGIES
• 11.8. CRODA INTERNATIONAL PLC
  • 11.8.1. COMPANY OVERVIEW
  • 11.8.2. FINANCIAL OVERVIEW
  • 11.8.3. PRODUCT OFFERED
  • 11.8.4. KEY DEVELOPMENTS
  • 11.8.5. SWOT ANALYSIS
  • 11.8.6. KEY STRATEGIES
• 11.9. AKZO NOBEL NV
  • 11.9.1. COMPANY OVERVIEW
  • 11.9.2. FINANCIAL OVERVIEW
  • 11.9.3. PRODUCT OFFERED
  • 11.9.4. KEY DEVELOPMENTS
  • 11.9.5. SWOT ANALYSIS
  • 11.9.6. KEY STRATEGIES
• 11.10. INNOPHOS
  • 11.10.1. COMPANY OVERVIEW
  • 11.10.2. FINANCIAL OVERVIEW
  • 11.10.3. PRODUCT OFFERED
  • 11.10.4. KEY DEVELOPMENTS
  • 11.10.5. SWOT ANALYSIS
  • 11.10.6. KEY STRATEGIES

12. APPENDIX

• 12.1. REFERENCES
• 12.2. RELATED REPORTS

LIST OF TABLES

• TABLE 1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SYNOPSIS, 2019-2032
• TABLE 2 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD MILLION)
• TABLE 3 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 5 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2019-2032 (USD MILLION)
• TABLE 7 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 8 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 9 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 10 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 11 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 12 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 13 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 14 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 15 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 16 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 17 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY 2019-2032 (USD MILLION)
• TABLE 18 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 19 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 20 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 21 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 22 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 23 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 24 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 25 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 26 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 27 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 28 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 29 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 30 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 31 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 32 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 33 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 34 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 35 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 36 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 37 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 38 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 39 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 40 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 41 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 42 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 43 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 44 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 45 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 46 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 47 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 48 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 49 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 50 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 51 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 52 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 53 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 54 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 55 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 56 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 57 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 58 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 59 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 60 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 61 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 62 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 63 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY 2019-2032 (USD MILLION)
• TABLE 64 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 65 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 66 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 67 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 68 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 69 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 70 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 71 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 72 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 73 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
• TABLE 74 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 75 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)

LIST OF FIGURES

• FIGURE 1 RESEARCH PROCESS
• FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
• FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
• FIGURE 4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY FUNCTION,
• FIGURE 5 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY PRODUCT,
• FIGURE 6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY APPLICATION,
• FIGURE 7 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY REGION,
• FIGURE 8 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY,
• FIGURE 9 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY,
• FIGURE 10 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY,
• FIGURE 11 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY,
• FIGURE 12 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY SHARE ANALYSIS (%),
• FIGURE 13 EVONIK INDUSTRIES AG: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 14 EVONIK INDUSTRIES AG: SWOT ANALYSIS
• FIGURE 15 BASF SE: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 16 BASF SE: SWOT ANALYSIS
• FIGURE 17 P&G CHEMICALS: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 18 P&G CHEMICALS: SWOT ANALYSIS
• FIGURE 19 AKZO NOBEL NV, INC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 20 AKZO NOBEL NV, INC: SWOT ANALYSIS
• FIGURE 21 FMC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 22 FMC CORPORATION: SWOT ANALYSIS
• FIGURE 23 THE DOW CHEMICAL COMPANY: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 24 THE DOW CHEMICAL COMPANY: SWOT ANALYSIS
• FIGURE 25 ASHLAND, INC.: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 26 ASHLAND, INC.: SWOT ANALYSIS
• FIGURE 27 CRODA INTERNATIONAL PLC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 28 CRODA INTERNATIONAL PLC: SWOT ANALYSIS
• FIGURE 29 FERRO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 30 FERRO CORPORATION: SWOT ANALYSIS
• FIGURE 31 INNOPHOS: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 32 INNOPHOS: SWOT ANALYSIS